Zacks Investment Research on MSN

CareDx reports positive data for AlloHeme in AML and MDS post HCT

CareDx CDNA recently announced clinical validation data supporting AlloHeme, its next-generation, blood-based monitoring test designed to predict relapses in patients with acute myeloid leukemia (AML) ...

Assessing CareDx (CDNA) Valuation After Positive AlloHeme Clinical Validation Results

CareDx (CDNA) has put its AlloHeme test in the spotlight after releasing pivotal clinical validation data showing earlier, highly sensitive relapse detection in acute myeloid leukemia and ...
Yahoo Finance

CareDx (CDNA) Loses 22.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

CareDx (CDNA) has been beaten down lately with too much selling pressure. While the stock has lost 22.5% over the past four weeks, there is light at the end of the tunnel as it is now in oversold ...
TweakTown

AMD CDNA 3: world's first exascale APU, CPU + GPU on same package

AMD's next-gen CDNA 3 architecture will be the first exascale APU design, packing both CPU and GPU chiplets on the same package. AMD has promised an insane 5x or higher (AI) performance-per-watt ...
Yahoo

New Supreme Court Decision Rules That cDNA Is Patentable What It Means for Research and Genetic Testing

In a unanimous decision last month, the Supreme Court ruled that naturally occurring genes are not patentable. But, said the Court, cDNA, a man-made copy of the genetic messenger in cells, is ...
PC World

How AMD’s new compute GPUs could alter Radeon’s gamer DNA forever

AMD gave us a glimpse of its future this week, divulging new information about its Radeon and Ryzen roadmaps during the company’s Financial Analyst Day. Lots of new information was disseminated, but ...
Seeking Alpha

CareDx Resolves Key Issues: Poised For Growth In Transplant Diagnostics

CDNA has resolved corporate instability and insurance issues, showing potential for sustainable growth with innovative transplant testing services like AlloSure, AlloMap, and HeartCare. CDNA's ...
Nasdaq

Interesting CDNA Put And Call Options For February 2026

Investors in CareDx Inc (Symbol: CDNA) saw new options begin trading this week, for the February 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...
Nature

cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells

Using the normalized data from our 9930 clone cDNA microarrays, gene lists were generated by SAM (version 1.12) for differentially expressed genes in the comparisons between C3.6 (moderately ...
Nature

Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity ...

To characterize molecular mechanism involved in pancreatic carcinogenesis, we analysed gene-expression profiles of 18 pancreatic tumors using a cDNA microarray representing 23 040 genes. As pancreatic ...
Nasdaq

Wells Fargo Upgrades CareDx (CDNA)

Fintel reports that on January 15, 2025, Wells Fargo upgraded their outlook for CareDx (NasdaqGM:CDNA) from Underweight to Equal-Weight. As of December 24, 2024, the average one-year price target for ...